Literature DB >> 14436248

A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity.

S I RAPAPORT, S B AMES, B J DUVALL.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS/complications; LUPUS ERYTHEMATOSUS/complications

Mesh：

Substances：

Year:  1960        PMID： 14436248

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  IDIOPATHIC CIRCULATING ANTI-FACTOR VIII ANTICOAGULANT.

Authors:  H F CORBUS
Journal:  Calif Med       Date:  1963-11

2.  Cryptococcal meningitis in steroid-treated systemic lupus erythematosus.

Authors:  M A Khan; S Sbar
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

3.  Autoimmunization-A Possible Mechanism of Tissue Injury : III-Clinical Aspects of Autoimmunity.

Authors:  J W Steiner; R Volpe
Journal:  Can Med Assoc J       Date:  1961-06-10       Impact factor: 8.262

4.  New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies.

Authors:  Savino Sciascia; Munther A Khamashta; Maria Laura Bertolaccini
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

5.  Study of haemostasis in nephropathies associated with pulmonary haemorrhage.

Authors:  G Boros; L Gofman; G Deák; A Hámori
Journal:  Int Urol Nephrol       Date:  1972       Impact factor: 2.370

6.  [Inhibitor of prothrombin activation].

Authors:  K Lechner; M Fischer; J Kühböck; C Steffen; W Waldhäusl
Journal:  Klin Wochenschr       Date:  1969-11-15

7.  Lupus anticoagulant after measles.

Authors:  W Muntean; W Petek
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

8.  Recurrent thrombosis in a child.

Authors:  Z Currimbhoy; E Kahn; T J Degnan; M Silverberg
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

9.  Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

Authors:  Simone Saibeni; Maria J Etchevers; Dolors Tassies; Julián Panés; Joan C Reverter; Silvio Danese; Josep M Piqué; Savino Bruno; Maurizio Vecchi; Antonio Gasbarrini; Miquel Sans
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571

10.  Factor V anticoagulants: clinical, biochemical, and immunological observations.

Authors:  D I Feinstein; S I Rapaport; W G McGehee; M J Patch
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.